| ?? |
?? ?? |
CAS |
MF |
 |
FENTICONAZOLE IMPURITY D |
|
|
|
|
BUPIVACAINE IMPURITY E |
|
|
 |
ERYTHROMYCIN B |
527-75-3 |
C37H67NO12 |
![(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid](/CAS/20130318/GIF/CB92605022.gif) |
(2S)-1-[2-Methylpropanoyl]-pyrrolidine-2-carboxylic Acid |
23500-15-4 |
C9H15NO3 |
 |
Zinc acexamate |
70020-71-2 |
C16H28N2O6Zn |
![??????????B(50mg)((2E)-1-[2-[(2RS)-2-?????-3-(??????)????]??]-3-?????-2-?-1-?)](/CAS/20180808/GIF/88308-22-9.gif) |
??????????B(50mg)((2E)-1-[2-[(2RS)-2-?????-3-(??????)????]??]-3-?????-2-?-1-?) |
88308-22-9 |
C21H25NO3 |
![4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO-](/CAS/GIF/84378-44-9.gif) |
4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID, 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO- |
84378-44-9 |
C13H10FN3O3 |
|
|
INSULIN ASPART |
116094-23-6 |
C256H381N65O79S6 |
 |
alpha-Methyl-4-biphenylacetic acid |
6341-72-6 |
C15H14O2 |
![(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide](/CAS/GIF/22568-64-5.gif) |
(±)-N-[3-acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]acetamide |
22568-64-5 |
C16H24N2O4 |
 |
CEFACLOR, DELTA-3-ISOMER (30 MG) |
152575-13-8 |
C15H14ClN3O4S |
 |
INDINAVIR (100 MG)F0D3080.971MG/MG(AI) |
180683-37-8 |
C36H49N5O5 |
 |
Labetalol IMpurity A |
1391051-99-2 |
C19H23NO4 |
 |
TRAMADOL IMPURITY E |
|
C16H25NO2 |
|
|
Fosinopril Related Compound B |
|
|
 |
????????? |
969-99-3 |
C17H19ClN2OS |
 |
INSULIN LISPRO (5.97 MG) |
133107-64-9 |
C257H383N65O77S6 |
![[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop](/CAS/20150408/GIF/99742-35-5.gif) |
[2S-[1[R*(R*)],2α,3aβ,6aβ]]-1-[2-[[3-Cyclohexyl-1-(ethoxycarbonyl)propyl]aMino]-1-oxoprop |
99742-35-5 |
C23H38N2O5 |
 |
Cetirizine Ethyl Ester (USP RC A) |
246870-46-2 |
C23H29ClN2O3 |
 |
LEVOCARNITINE RELATED COMPOUND A (100 MG) (3-CARBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE) |
6538-82-5 |
C7H13ClNO2 |
 |
Levomepromazine hydrochloride |
1236-99-3 |
C19H24N2OS.ClH |
|
|
Citalopram Related Compound E |
|
|
 |
1-Cyano-3-isopropylguanidine |
44830-55-9 |
C5H10N4 |
 |
LevetiracetaM IMpurity B |
358629-47-7 |
C8H12N2O2 |
 |
Loratadine EP IMpurity F |
125743-80-8 |
C22H24ClFN2O2 |
 |
FLUCONAZOLE IMPURITY B |
|
C13H12F2N6O |
 |
4-Nitro-2-phenoxyaniline |
5422-92-4 |
C12H10N2O3 |
 |
4'-(pyrimidin-2-ylsulphamoyl)acetanilide |
127-74-2 |
C12H12N4O3S |
 |
Fosinopril Related Compound D |
1356353-41-7 |
C30H47NNaO7P |
 |
Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride) |
13590-98-2 |
C14H14Cl3N5 |
 |
Ticabesone Propionate |
73205-13-7 |
C25H32F2O5S |
|
|
OXALIPLATIN IMPURITY B |
|
|
 |
PYRANTEL IMPURITY A |
36700-38-6 |
C11H14N2S |
 |
estra-1,3,5(10)-triene-3,17beta-diol 17-butyrate |
18069-79-9 |
C22H30O3 |
 |
N-Succinyl-L-tyrosine |
374816-32-7 |
C13H15NO6 |
![1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride](/CAS/GIF/16899-81-3.gif) |
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride |
16899-81-3 |
C11H15NO3.ClH |
 |
Talampicillin hydrochloride |
39878-70-1 |
C24H23N3O6S.ClH |
![[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt](/CAS/GIF/545338-89-4.gif) |
[3-[2-(diMethylaMino)ethyl]-2-[[3-[2-(diMethylaMino)ethyl]-1H-indol-5-yl]Methyl]-1H-indol-5-yl]-N-MethylMethanesulfonaMide, succinate salt |
545338-89-4 |
C27H37N5O2S |
 |
Meta-Fexofenadine |
479035-75-1 |
C32H39NO4 |
 |
5-Chloro-6-(2,3-dichlorophenoxy)-1,3-dihydro-2H-benziMidazol-2-one |
1201920-88-8 |
C13H7Cl3N2O2 |
 |
DIAZEPAM RELATED COMPOUND B (25 MG) (3-AMINO-6-CHLORO-1-METHYL-4-PHENYLCARBOSTYRIL) |
5220-02-0 |
C16H13ClN2O |
|
|
BUPIVACAINE IMPURITY B |
|
|
 |
Ofloxacin-d3 |
1173147-91-5 |
C18H17D3FN3O4 |
 |
Platinum, (1,2-cyclohexanediamine-N,N')dinitrato-,(sp-4-2, 1R-trans)- |
66900-68-3 |
C6H12N4O6Pt |
 |
Lisinopril Cyclohexyl Analog |
1132650-67-9 |
C21H37N3O5 |
|
|
?????? |
68525-86-0 |
|
![2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-](/CAS/GIF/41411-66-9.gif) |
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]- |
41411-66-9 |
C22H25ClN2O8 |
 |
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) |
35888-94-9 |
C19H16O4 |
 |
?????(????????) |
878143-33-0 |
C20H24N2O6S |
 |
Olopatadine N-Oxide |
203188-31-2 |
C21H23NO4 |
|
|
HYOSCINE BUTYLBROMIDE IMPURITY E |
|
|
![D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-](/CAS/GIF/105816-06-6.gif) |
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis- |
105816-06-6 |
C19H27NO3 |
|
|
WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) |
37209-23-7 |
|
|
|
OXALIPLATIN IMPURITY D |
|
|
 |
Febantel D6 |
1173021-79-8 |
C20H16D6N4O6S |
 |
Albendazole-2-aMinosulfone-D3 hydrochloride |
1435902-07-0 |
C10H14ClN3O2S |
|
|
HYDRANAL(R)-WORKING MEDIUM K |
|
|
 |
(9S,13S,14S)-3-METHOXYMORPHINAN HYDROCHLORIDE |
1087-69-0 |
C17H24ClNO |
 |
??? ??? |
64-31-3 |
C18H25NO8S |
 |
S(+)-3 4-MDMA HCL |
64057-70-1 |
C11H16ClNO2 |
 |
8-CHLORO-2,3,4,5-TETRAHYDRO-5-PHENYL-1H-3-BENZAZEPIN-7-OL-(5R) |
106648-57-1 |
C16H16ClNO |
 |
rac Metoprolol-d7 |
959787-96-3 |
C15H25NO3 |
 |
Promethazine-d6 Hydrochloride Salt |
1189947-02-1 |
C17H21ClN2S |
 |
Naproxen-d3 |
958293-79-3 |
C14H14O3 |
 |
4-Hydroxy-tetraMisole |
6649-26-9 |
C11H12N2OS |
 |
Oxibendazole-aMine-D7 |
1448346-35-7 |
C10H13N3O |
 |
Delta9-Tetrahydrocannabinolic acid A solution |
23978-85-0 |
C22H30O4 |
 |
(+/-)-BUTACLAMOL HCL |
36504-94-6 |
C25H31NO.ClH |
 |
S(-)-CATHINONE HYDROCHLORIDE |
71031-15-7 |
C9H11NO |
 |
(+/-)-2,5-DIMETHOXY-4-BROMO-AMPHETAMINE HYDROBROMIDE |
53581-53-6 |
C11H17Br2NO2 |
|
|
Fluorexon |
154071-48-4 |
C30H26N2O13 |
|
|
KAVERGAL |
|
|
 |
Vedaprofen-d3 |
1185054-34-5 |
C19H22O2 |
 |
Oxibendazole D7 |
1173019-44-7 |
C12H8D7N3O3 |
 |
Albendazole sulfone-D3 |
1448345-60-5 |
C12H12D3N3O4S |
|
|
HYDRANAL-LIPOSOLVER MH |
|
|
 |
2-Methyl-3-isothiazolone-d3 Hydrochloride |
1329509-49-0 |
C4H6ClNOS |
 |
5-HydroxyMebendazole-D3 |
1173020-86-4 |
C16H15N3O3 |
 |
Nitrofurazone-13C,15N2 |
1217220-85-3 |
C6H6N4O4 |
 |
HYDROCODONE-D3 |
136765-36-1 |
C18H18D3NO3 |
 |
METHYLENEDIOXY-3,4-AMPHETAMINE HYDROCHLORIDE CI (25 MG) (AS) (MDA) |
6292-91-7 |
C10H14ClNO2 |
 |
PMA HYDROCHLORIDE |
52740-56-4 |
C10H16ClNO |
 |
Nalidixic Acid-d5 |
1189467-36-4 |
C12H12N2O3 |
 |
Adapalene-d3 |
1276433-89-6 |
C28H28O3 |
 |
HEXESTROL DIPROPIONATE |
4825-53-0 |
C24H30O4 |
 |
M-HYDROXYBENZOYLECGONINE |
129944-99-6 |
C16H19NO5 |
 |
UMF 060 |
82050-12-2 |
C16H14FN3O3 |
 |
Flumequine-13C3 |
1185049-09-5 |
C14H12FNO3 |
 |
Flubendazole D3 |
1173021-08-3 |
詳詢 |
 |
Furazolidone-d4 |
1217222-76-8 |
C8H7N3O5 |
 |
ALLOPREGNANETRIONE |
2089-06-7 |
C21H30O3 |
 |
(+/-)-N-ALLYLNORMETAZOCINE |
7619-35-4 |
C17H23NO.ClH |
 |
buquinolate |
5486-03-3 |
C20H27NO5 |
 |
CAFFEINE (TRIMETHYL-13C3) |
78072-66-9 |
C8H12N4O2 |
 |
Carazolol D7 |
1173021-02-7 |
C18H22N2O2 |
 |
Fenbendazole-aMine hydrochloride |
1448346-29-9 |
C13H12ClN3S |
 |
Metronidazole-13C2,15N2 |
1173020-03-5 |
C6H9N3O3 |
 |
BENZOYLECGONINE-D3 TETRAHYDRATE--DEA SCH |
115732-68-8 |
C16H16D3NO4 |
 |
P-??????????? |
90899-22-2 |
C16H19NO5 |
 |
TRIMETHOPRIM-D9 MAJOR |
1189460-62-5 |
C14H18N4O3 |